The National Institute for Drug and Food Surveillance (INVIMA) reports that, after receiving alerts from Latin American health agencies about possible adverse effects linked to the use of stannous fluoride toothpaste, health surveillance protocols were activated in Colombia to protect consumers.

Since March 2025, when Brazil issued the initial alert, INVIMA has issued a bulletin, strengthened market supervision, and investigated the presence and composition of these products in the country.

It was confirmed that the specific toothpaste alerted in Brazil is not marketed in Colombia. However, within the framework of these investigations, INVIMA received 30 reports of adverse effects, which were reviewed along with the corresponding health notifications.

WHOM DOES IT IMPACT?

The direct impact is on consumers, the healthcare sector, manufacturers, and importers.

CONCLUSION:

INVIMA's actions strengthen confidence in health surveillance, limiting the population's exposure to risks and ensuring transparency in the management of mass consumption products.